CS logo
small CS logo
University of Kansas Cancer Center - Lee's Summit

Lees Summit, Missouri, United States
Cancer treatment center in Lee's Summit, Missouri
4881 NE Goodview Cir, Lee's Summit, MO 64064

About University of Kansas Cancer Center - Lee's Summit


"The University of Kansas Cancer Center offers treatment in Lee’s Summit, Missouri. Patients have even greater access to treatment options and clinical trials available only at a National Cancer Institute-designated cancer center."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
75
SWOG Cancer Research Network
36
NRG Oncology
15
Alliance for Clinical Trials in Oncology
14
University of Kansas Medical Center
9
Radiation Therapy Oncology Group
6
ECOG-ACRIN Cancer Research Group
4
NSABP Foundation Inc
3
Priyanka Sharma
3
Qamar Khan
3
Pfizer
2
Total Rows: 17

Clinical Trials at University of Kansas Cancer Center - Lee's Summit


During the past decade, University of Kansas Cancer Center - Lee's Summit conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 55 clinical trials were completed, i.e. on average, 49.5% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 38 clinical trials were completed. i.e. 131% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111110101717131331311515886600335544558814141010Started TrialsCompleted Trails20152016201720182019202020212022010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
2004-08-01
2009-05-01
Completed
100
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
2007-05-08
2030-10-01
Active, not recruiting
788
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
2007-09-01
2017-06-01
Completed
406
Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)
2008-01-31
2010-05-20
Completed
192
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
2008-12-01
2016-12-01
Completed
59

Rows per page:

1–100 of 177

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Kansas Cancer Center - Lee's Summit" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "NRG Oncology" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored and "University of Kansas Medical Center" with 14 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center - Lee's Summit" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Novartis Pharmaceuticals" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 36 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 75National CancerInstitute (NCI): 75SWOG Cancer ResearchNetwork: 36SWOG Cancer ResearchNetwork: 36NRG Oncology: 15NRG Oncology: 15Alliance for ClinicalTrials in Oncology: 14Alliance for ClinicalTrials in Oncology: 14University of KansasMedical Center: 9University of KansasMedical Center: 9Radiation TherapyOncology Group: 6Radiation TherapyOncology Group: 6ECOG-ACRIN CancerResearch Group: 4ECOG-ACRIN CancerResearch Group: 4NSABP Foundation Inc: 3NSABP Foundation Inc: 3Priyanka Sharma: 3Priyanka Sharma: 3Qamar Khan: 3Qamar Khan: 3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 77National CancerInstitute (NCI): 77NRG Oncology: 17NRG Oncology: 17Canadian Cancer Trials Group: 7Canadian Cancer Trials Group: 7Novartis Pharmaceuticals: 3Novartis Pharmaceuticals: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2Genentech, Inc.: 2Genentech, Inc.: 2Gilead Sciences: 2Gilead Sciences: 2Medivation, Inc.: 2Medivation, Inc.: 2

Clinical Trials Conditions at University of Kansas Cancer Center - Lee's Summit


According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center - Lee's Summit" are "Breast Cancer" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Prostate Cancer" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "University of Kansas Cancer Center - Lee's Summit" in a lesser frequency.

Clinical Trials Intervention Types at University of Kansas Cancer Center - Lee's Summit


Most popular intervention types in "University of Kansas Cancer Center - Lee's Summit" are "Drug" (143 trials), "Other" (84 trials), "Biological" (62 trials), "Procedure" (48 trials) and "Radiation" (45 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (33 trials), "Biospecimen Collection" (29 trials), "Computed Tomography" (28 trials) and "Nivolumab" (22 trials). Other intervention names were less common.

Clinical Trials Genders at University of Kansas Cancer Center - Lee's Summit


The vast majority of trials in "University of Kansas Cancer Center - Lee's Summit" are 140 trials for "All" genders, 19 trials for "Female" genders and 18 trials for "Male" genders.

Clinical Trials Status at University of Kansas Cancer Center - Lee's Summit


Currently, there are NaN active trials in "University of Kansas Cancer Center - Lee's Summit". undefined are not yet recruiting, 53 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in University of Kansas Cancer Center - Lee's Summit, 4 suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Kansas Cancer Center - Lee's Summit, 19 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 100Phase 2: 100Phase 3: 80Phase 3: 80Phase 1: 19Phase 1: 19Not Applicable: 4Not Applicable: 4

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 88Active, not recruiting: 88Recruiting: 53Recruiting: 53Completed: 30Completed: 30Suspended: 4Suspended: 4Terminated: 2Terminated: 2